Gallium 67 imaging in monitoring lymphoma response to treatment
Journal Article
·
· Cancer (Philadelphia); (United States)
DOI:https://doi.org/10.1002/1097-0142(19880615)61:12<2439::AID-CNCR2820611208>3.0.CO;2-Q·
OSTI ID:7069508
The value of gallium 67 (Ga) imaging in monitoring lymphoma response to treatment was assessed in 25 patients with Ga-avid tumors and compared to body computed tomography (CT), chest radiographs, and palpation of tumor infiltrated peripheral lymph nodes. Ga imaging was negative in 95% (20/21) of the patients who were clinically considered to be in remission and in whom treatment was stopped. The disease did not recur during a follow-up of 12 to 26 months in 15 patients. Six patients developed recurrence of the disease 3 to 12 months after treatment was stopped. In all six patients Ga imaging became positive again at the time of the appearance of active disease. In the group of patients in remission, CT was negative in 57% (11/19), chest x-rays in 55% (6/11) and peripheral lymph nodes were palpated in none of the patients (13/13). In four patients that did not achieve remission after treatment, Ga scans were positive. Ga imaging appears useful in monitoring lymphoma response to treatment. This is probably because Ga imaging monitors tumor cell viability, whereas body CT and chest radiographs show the tumor mass, which may consist of fibrotic or necrotic tissue.
- Research Organization:
- Rambam Medical Center, Haifa (Israel)
- OSTI ID:
- 7069508
- Journal Information:
- Cancer (Philadelphia); (United States), Journal Name: Cancer (Philadelphia); (United States) Vol. 61:12; ISSN CANCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma
Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy
CT evaluation of cardiophrenic angle lymph nodes in patients with malignant lymphoma
Journal Article
·
Fri Nov 30 23:00:00 EST 1990
· Journal of Clinical Oncology; (USA)
·
OSTI ID:6323095
Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy
Journal Article
·
Wed Nov 30 23:00:00 EST 1988
· AJR, Am. J. Roentgenol.; (United States)
·
OSTI ID:6601965
CT evaluation of cardiophrenic angle lymph nodes in patients with malignant lymphoma
Journal Article
·
Mon Oct 01 00:00:00 EDT 1984
· AJR, Am. J. Roentgenol.; (United States)
·
OSTI ID:6444530
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
550602 -- Medicine-- External Radiation in Diagnostics-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMAL CELLS
BETA DECAY RADIOISOTOPES
BIOMEDICAL RADIOGRAPHY
COMPARATIVE EVALUATIONS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
GALLIUM 67
GALLIUM ISOTOPES
IMMUNE SYSTEM DISEASES
INTERMEDIATE MASS NUCLEI
ISOTOPES
LYMPH NODES
LYMPHATIC SYSTEM
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOLOGY
SENSITIVITY ANALYSIS
TUMOR CELLS
VIABILITY
550602 -- Medicine-- External Radiation in Diagnostics-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMAL CELLS
BETA DECAY RADIOISOTOPES
BIOMEDICAL RADIOGRAPHY
COMPARATIVE EVALUATIONS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
GALLIUM 67
GALLIUM ISOTOPES
IMMUNE SYSTEM DISEASES
INTERMEDIATE MASS NUCLEI
ISOTOPES
LYMPH NODES
LYMPHATIC SYSTEM
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOLOGY
SENSITIVITY ANALYSIS
TUMOR CELLS
VIABILITY